Non-Current Liabilities
Total Liabilities
West Pharmaceutical Services Total Liabilities decreased by 16.6% to $16.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 31.4%, from $24.20M to $16.60M. Over 5 years (FY 2020 to FY 2025), Total Liabilities shows a downward trend with a -9.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ4 2015
Last reportedQ1 2026
How to read this metric
A rising trend may indicate aggressive expansion or liquidity pressure, while a declining trend suggests deleveraging and improved balance sheet health.
Detailed definition
This represents the aggregate sum of all current and non-current financial obligations owed by the company to external p...
Peer comparison
Used across all industries to assess the overall debt burden relative to equity and assets.
Metric ID:
total_liabilitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $22.70M | $22.00M | $23.20M | $23.90M | $25.60M | $26.30M | $18.80M | $17.50M | $36.40M | $25.40M | $16.20M | $24.10M | $29.10M | $25.00M | $32.50M | $24.20M | $58.90M | $39.90M | $19.90M | $16.60M |
| QoQ Change | — | -3.1% | +5.5% | +3.0% | +7.1% | +2.7% | -28.5% | -6.9% | +108.0% | -30.2% | -36.2% | +48.8% | +20.7% | -14.1% | +30.0% | -25.5% | +143.4% | -32.3% | -50.1% | -16.6% |
| YoY Change | — | — | — | — | +12.8% | +19.5% | -19.0% | -26.8% | +42.2% | -3.4% | -13.8% | +37.7% | -20.1% | -1.6% | +100.6% | +0.4% | +102.4% | +59.6% | -38.8% | -31.4% |
Range$16.20M – $58.90M
CAGR-6.4%
Avg YoY Growth+13.8%
Median YoY Growth-0.6%
Current Streak3 quarters decline
Total Liabilities at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's total liabilities?
- West Pharmaceutical Services (WST) reported total liabilities of $16.60M in Q1 2026.
- How has West Pharmaceutical Services's total liabilities changed year-over-year?
- West Pharmaceutical Services's total liabilities decreased by 31.4% year-over-year, from $24.20M to $16.60M.
- What is the long-term trend for West Pharmaceutical Services's total liabilities?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's total liabilities has grown at a -9.8% compound annual growth rate (CAGR), from $33.40M to $19.90M.
- What does total liabilities mean?
- The total amount of money the company owes to all creditors and stakeholders.